The pharmaceutical landscape is undergoing a seismic shift. If you looked at the top-selling drugs twenty years ago, you’d find mostly "small molecule" pills, aspirin, statins, and Ibuprofen. Today, the leaderboard is dominated by biologics. These complex, large-molecule therapies derived from living organisms are treating previously "untreatable" diseases, from chronic autoimmune...
According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032.
cGMP process development represents the critical discipline of systematically designing,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek